Avidity Partners Management LP Immunic, Inc. Transaction History
Avidity Partners Management LP
- $1.63 Billion
- Q3 2024
A detailed history of Avidity Partners Management LP transactions in Immunic, Inc. stock. As of the latest transaction made, Avidity Partners Management LP holds 8,266,000 shares of IMUX stock, worth $8.51 Million. This represents 0.84% of its overall portfolio holdings.
Number of Shares
8,266,000
Previous 8,902,972
7.15%
Holding current value
$8.51 Million
Previous $9.88 Million
38.01%
% of portfolio
0.84%
Previous 0.49%
Shares
2 transactions
Others Institutions Holding IMUX
# of Institutions
70Shares Held
56.2MCall Options Held
100Put Options Held
350K-
Bvf Inc San Francisco, CA8.9MShares$9.17 Million0.47% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT7.29MShares$7.51 Million1.02% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.59MShares$5.76 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X05.1MShares$5.25 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.7MShares$4.84 Million0.0% of portfolio
About IMMUNIC, INC.
- Ticker IMUX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,565,000
- Market Cap $31.5M
- Description
- Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...